Clinical Trials

ChemDiv buys Russia’s Prudentas

ChemDiv buys Russia’s Prudentas

By Gareth Macdonbald

US clinical trials firm ChemDiv has bought Russian CRO Prudentas, boosting its presence in the country at a time when the treatment naïve populations in Eastern Europe are increasingly catching the eye of the global pharma and biotech industries.

eClinical news brief

eClinical news brief

By staff reporter

Outsourcing-Pharma tracks the latest eClinical movements, featuring
Perceptive Informatics, Almac Clinical Technologies, Aptuit, INC
Research and OmniComm Systems.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All